Index by author
November 01, 1994; Volume 22,Issue 6
A
Alton, K B
- You have accessUrinary metabolites of (R),(R)-labetalol.K B Alton, T M Chan and B N PramanikDrug Metabolism and Disposition November 1994, 22 (6) 866-872;
Anders, M W
- You have accessTissue distribution and stereoselectivity of remacemide-glycine hydrolase.H Heyn, Y G Bankmann and M W AndersDrug Metabolism and Disposition November 1994, 22 (6) 973-974;
Ardouin, T
- You have accessPharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis.E Ezan, P Carde, J Le Kerneau, T Ardouin, F Thomas, F Isnard, E Deschamps de Paillette and J M GrognetDrug Metabolism and Disposition November 1994, 22 (6) 843-848;
B
Babu, S R
- You have accessGlucuronidation of N-acetylbenzidine by human liver.S R Babu, V M Lakshmi, T V Zenser and B B DavisDrug Metabolism and Disposition November 1994, 22 (6) 922-927;
Bankmann, Y G
- You have accessTissue distribution and stereoselectivity of remacemide-glycine hydrolase.H Heyn, Y G Bankmann and M W AndersDrug Metabolism and Disposition November 1994, 22 (6) 973-974;
Barnett, J L
- You have accessInterpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.K S Lown, J C Kolars, K E Thummel, J L Barnett, K L Kunze, S A Wrighton and P B WatkinsDrug Metabolism and Disposition November 1994, 22 (6) 947-955;
Boelsterli, U A
- You have accessMechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct.A Kretz-Rommel and U A BoelsterliDrug Metabolism and Disposition November 1994, 22 (6) 956-961;
Bonner, H S
- You have accessMetabolic pathways of WR-2721 (ethyol, amifostine) in the BALB/c mouse.L M Shaw, H S Bonner and D Q BrownDrug Metabolism and Disposition November 1994, 22 (6) 895-902;
Boyd, S A
- You have accessThe orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.J F Denissen, B A Grabowski, M K Johnson, S A Boyd, J T Uchic, H Stein, S Cepa and P HillDrug Metabolism and Disposition November 1994, 22 (6) 880-888;
Brennan, J M
- You have accessStereoselective pharmacokinetics of L-buthionine SR-sulfoximine in patients with cancer.F P Lacreta, J M Brennan, T C Hamilton, R F Ozols and P J O'DwyerDrug Metabolism and Disposition November 1994, 22 (6) 835-842;
Brown, D Q
- You have accessMetabolic pathways of WR-2721 (ethyol, amifostine) in the BALB/c mouse.L M Shaw, H S Bonner and D Q BrownDrug Metabolism and Disposition November 1994, 22 (6) 895-902;
Brown, R P
- You have accessA comprehensive evaluation of the vial equilibration method for quantification of the metabolism of volatile organic chemicals. Trichloroethylene.C Kim, R O Manning, R P Brown and J V BrucknerDrug Metabolism and Disposition November 1994, 22 (6) 858-865;
Bruckner, J V
- You have accessA comprehensive evaluation of the vial equilibration method for quantification of the metabolism of volatile organic chemicals. Trichloroethylene.C Kim, R O Manning, R P Brown and J V BrucknerDrug Metabolism and Disposition November 1994, 22 (6) 858-865;
C
Carde, P
- You have accessPharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis.E Ezan, P Carde, J Le Kerneau, T Ardouin, F Thomas, F Isnard, E Deschamps de Paillette and J M GrognetDrug Metabolism and Disposition November 1994, 22 (6) 843-848;
Cepa, S
- You have accessThe orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.J F Denissen, B A Grabowski, M K Johnson, S A Boyd, J T Uchic, H Stein, S Cepa and P HillDrug Metabolism and Disposition November 1994, 22 (6) 880-888;
Chan, T M
- You have accessUrinary metabolites of (R),(R)-labetalol.K B Alton, T M Chan and B N PramanikDrug Metabolism and Disposition November 1994, 22 (6) 866-872;
Chauret, N
- You have accessIncreased cosedimentation of cytosolic glutathione S-transferases with microsomal fractions prepared from frozen rat liver.A E Cribb, G P Griffin, S P Spielberg, T H Rushmore, N Chauret and D A Nicoll-GriffithDrug Metabolism and Disposition November 1994, 22 (6) 969-972;
Coddington, A B
- You have accessHepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites.L E Los, S M Pitzenberger, H G Ramjit, A B Coddington and H D ColbyDrug Metabolism and Disposition November 1994, 22 (6) 903-908;
Colby, H D
- You have accessHepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites.L E Los, S M Pitzenberger, H G Ramjit, A B Coddington and H D ColbyDrug Metabolism and Disposition November 1994, 22 (6) 903-908;
Crawford, K
- You have accessTerfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals.M Jurima-Romet, K Crawford, T Cyr and T InabaDrug Metabolism and Disposition November 1994, 22 (6) 849-857;
Cribb, A E
- You have accessIncreased cosedimentation of cytosolic glutathione S-transferases with microsomal fractions prepared from frozen rat liver.A E Cribb, G P Griffin, S P Spielberg, T H Rushmore, N Chauret and D A Nicoll-GriffithDrug Metabolism and Disposition November 1994, 22 (6) 969-972;
Cyr, T
- You have accessTerfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals.M Jurima-Romet, K Crawford, T Cyr and T InabaDrug Metabolism and Disposition November 1994, 22 (6) 849-857;
D
Davis, B B
- You have accessGlucuronidation of N-acetylbenzidine by human liver.S R Babu, V M Lakshmi, T V Zenser and B B DavisDrug Metabolism and Disposition November 1994, 22 (6) 922-927;
Dehal, S S
- You have accessMetabolism of the proestrogenic pesticide methoxychlor by hepatic P450 monooxygenases in rats and humans. Dual pathways involving novel ortho ring-hydroxylation by CYP2B.S S Dehal and D KupferDrug Metabolism and Disposition November 1994, 22 (6) 937-946;
Denissen, J F
- You have accessThe orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.J F Denissen, B A Grabowski, M K Johnson, S A Boyd, J T Uchic, H Stein, S Cepa and P HillDrug Metabolism and Disposition November 1994, 22 (6) 880-888;
Deschamps de Paillette, E
- You have accessPharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis.E Ezan, P Carde, J Le Kerneau, T Ardouin, F Thomas, F Isnard, E Deschamps de Paillette and J M GrognetDrug Metabolism and Disposition November 1994, 22 (6) 843-848;
E
Ehlers, K
- You have accessIdentification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos.G Tzimas, J O Sass, W Wittfoht, M M Elmazar, K Ehlers and H NauDrug Metabolism and Disposition November 1994, 22 (6) 928-936;
Elmazar, M M
- You have accessIdentification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos.G Tzimas, J O Sass, W Wittfoht, M M Elmazar, K Ehlers and H NauDrug Metabolism and Disposition November 1994, 22 (6) 928-936;
Ezan, E
- You have accessPharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis.E Ezan, P Carde, J Le Kerneau, T Ardouin, F Thomas, F Isnard, E Deschamps de Paillette and J M GrognetDrug Metabolism and Disposition November 1994, 22 (6) 843-848;
G
Grabowski, B A
- You have accessThe orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.J F Denissen, B A Grabowski, M K Johnson, S A Boyd, J T Uchic, H Stein, S Cepa and P HillDrug Metabolism and Disposition November 1994, 22 (6) 880-888;
Griffin, G P
- You have accessIncreased cosedimentation of cytosolic glutathione S-transferases with microsomal fractions prepared from frozen rat liver.A E Cribb, G P Griffin, S P Spielberg, T H Rushmore, N Chauret and D A Nicoll-GriffithDrug Metabolism and Disposition November 1994, 22 (6) 969-972;
Grognet, J M
- You have accessPharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis.E Ezan, P Carde, J Le Kerneau, T Ardouin, F Thomas, F Isnard, E Deschamps de Paillette and J M GrognetDrug Metabolism and Disposition November 1994, 22 (6) 843-848;
H
Hall, S D
- You have accessRelationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.S D Hall, M A Hamman, A E Rettie, L C Wienkers, W F Trager, M Vandenbranden and S A WrightonDrug Metabolism and Disposition November 1994, 22 (6) 975-978;
Hamilton, T C
- You have accessStereoselective pharmacokinetics of L-buthionine SR-sulfoximine in patients with cancer.F P Lacreta, J M Brennan, T C Hamilton, R F Ozols and P J O'DwyerDrug Metabolism and Disposition November 1994, 22 (6) 835-842;
Hamman, M A
- You have accessRelationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.S D Hall, M A Hamman, A E Rettie, L C Wienkers, W F Trager, M Vandenbranden and S A WrightonDrug Metabolism and Disposition November 1994, 22 (6) 975-978;
Hara, K
- You have accessIn vitro metabolism of dorzolamide, a novel potent carbonic anhydrase inhibitor, in rat liver microsomes.T Hasegawa, K Hara, T Kenmochi and S HataDrug Metabolism and Disposition November 1994, 22 (6) 916-921;
Hasegawa, T
- You have accessIn vitro metabolism of dorzolamide, a novel potent carbonic anhydrase inhibitor, in rat liver microsomes.T Hasegawa, K Hara, T Kenmochi and S HataDrug Metabolism and Disposition November 1994, 22 (6) 916-921;
Hata, S
- You have accessIn vitro metabolism of dorzolamide, a novel potent carbonic anhydrase inhibitor, in rat liver microsomes.T Hasegawa, K Hara, T Kenmochi and S HataDrug Metabolism and Disposition November 1994, 22 (6) 916-921;
Heyn, H
- You have accessTissue distribution and stereoselectivity of remacemide-glycine hydrolase.H Heyn, Y G Bankmann and M W AndersDrug Metabolism and Disposition November 1994, 22 (6) 973-974;
Hill, P
- You have accessThe orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.J F Denissen, B A Grabowski, M K Johnson, S A Boyd, J T Uchic, H Stein, S Cepa and P HillDrug Metabolism and Disposition November 1994, 22 (6) 880-888;
Hirata, K
- You have accessSpecies differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl)phthalate, a peroxisome proliferator.M Hosokawa, K Hirata, F Nakata, T Suga and T SatohDrug Metabolism and Disposition November 1994, 22 (6) 889-894;
Horie, T
- You have accessCytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.Y Masubuchi, S Hosokawa, T Horie, T Suzuki, S Ohmori, M Kitada and S NarimatsuDrug Metabolism and Disposition November 1994, 22 (6) 909-915;
Hosokawa, M
- You have accessSpecies differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl)phthalate, a peroxisome proliferator.M Hosokawa, K Hirata, F Nakata, T Suga and T SatohDrug Metabolism and Disposition November 1994, 22 (6) 889-894;
Hosokawa, S
- You have accessCytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.Y Masubuchi, S Hosokawa, T Horie, T Suzuki, S Ohmori, M Kitada and S NarimatsuDrug Metabolism and Disposition November 1994, 22 (6) 909-915;
I
Inaba, T
- You have accessTerfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals.M Jurima-Romet, K Crawford, T Cyr and T InabaDrug Metabolism and Disposition November 1994, 22 (6) 849-857;
Isnard, F
- You have accessPharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis.E Ezan, P Carde, J Le Kerneau, T Ardouin, F Thomas, F Isnard, E Deschamps de Paillette and J M GrognetDrug Metabolism and Disposition November 1994, 22 (6) 843-848;
J
Jackson, B J
- You have accessTheophylline N-demethylations as probes for P4501A1 and P4501A2.M A Sarkar and B J JacksonDrug Metabolism and Disposition November 1994, 22 (6) 827-834;
Johnson, M K
- You have accessThe orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.J F Denissen, B A Grabowski, M K Johnson, S A Boyd, J T Uchic, H Stein, S Cepa and P HillDrug Metabolism and Disposition November 1994, 22 (6) 880-888;
Jurima-Romet, M
- You have accessTerfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals.M Jurima-Romet, K Crawford, T Cyr and T InabaDrug Metabolism and Disposition November 1994, 22 (6) 849-857;
K
Kenmochi, T
- You have accessIn vitro metabolism of dorzolamide, a novel potent carbonic anhydrase inhibitor, in rat liver microsomes.T Hasegawa, K Hara, T Kenmochi and S HataDrug Metabolism and Disposition November 1994, 22 (6) 916-921;
Kim, C
- You have accessA comprehensive evaluation of the vial equilibration method for quantification of the metabolism of volatile organic chemicals. Trichloroethylene.C Kim, R O Manning, R P Brown and J V BrucknerDrug Metabolism and Disposition November 1994, 22 (6) 858-865;
Kitada, M
- You have accessCytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.Y Masubuchi, S Hosokawa, T Horie, T Suzuki, S Ohmori, M Kitada and S NarimatsuDrug Metabolism and Disposition November 1994, 22 (6) 909-915;
Kolars, J C
- You have accessInterpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.K S Lown, J C Kolars, K E Thummel, J L Barnett, K L Kunze, S A Wrighton and P B WatkinsDrug Metabolism and Disposition November 1994, 22 (6) 947-955;
Kretz-Rommel, A
- You have accessMechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct.A Kretz-Rommel and U A BoelsterliDrug Metabolism and Disposition November 1994, 22 (6) 956-961;
Kunze, K L
- You have accessInterpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.K S Lown, J C Kolars, K E Thummel, J L Barnett, K L Kunze, S A Wrighton and P B WatkinsDrug Metabolism and Disposition November 1994, 22 (6) 947-955;
Kupfer, D
- You have accessMetabolism of the proestrogenic pesticide methoxychlor by hepatic P450 monooxygenases in rats and humans. Dual pathways involving novel ortho ring-hydroxylation by CYP2B.S S Dehal and D KupferDrug Metabolism and Disposition November 1994, 22 (6) 937-946;
L
Lacreta, F P
- You have accessStereoselective pharmacokinetics of L-buthionine SR-sulfoximine in patients with cancer.F P Lacreta, J M Brennan, T C Hamilton, R F Ozols and P J O'DwyerDrug Metabolism and Disposition November 1994, 22 (6) 835-842;
Lakshmi, V M
- You have accessGlucuronidation of N-acetylbenzidine by human liver.S R Babu, V M Lakshmi, T V Zenser and B B DavisDrug Metabolism and Disposition November 1994, 22 (6) 922-927;
Lee, C
- You have accessIdentification of hepatocytes as the major locus of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1-related P450s, TCDDAA and TCDDAHH, in chick embryo liver.L Paroli, C Lee and A B RifkindDrug Metabolism and Disposition November 1994, 22 (6) 962-968;
Le Kerneau, J
- You have accessPharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis.E Ezan, P Carde, J Le Kerneau, T Ardouin, F Thomas, F Isnard, E Deschamps de Paillette and J M GrognetDrug Metabolism and Disposition November 1994, 22 (6) 843-848;
Linhart, I
- You have accessSolvolysis of butadiene monoxide.I LinhartDrug Metabolism and Disposition November 1994, 22 (6) 820-821;
Los, L E
- You have accessHepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites.L E Los, S M Pitzenberger, H G Ramjit, A B Coddington and H D ColbyDrug Metabolism and Disposition November 1994, 22 (6) 903-908;
Lown, K S
- You have accessInterpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.K S Lown, J C Kolars, K E Thummel, J L Barnett, K L Kunze, S A Wrighton and P B WatkinsDrug Metabolism and Disposition November 1994, 22 (6) 947-955;
M
Mangold, J B
- You have accessPharmacokinetics and metabolism of cyclosporin G in humans.J B Mangold, H F Schran and F L TseDrug Metabolism and Disposition November 1994, 22 (6) 873-879;
Manning, R O
- You have accessA comprehensive evaluation of the vial equilibration method for quantification of the metabolism of volatile organic chemicals. Trichloroethylene.C Kim, R O Manning, R P Brown and J V BrucknerDrug Metabolism and Disposition November 1994, 22 (6) 858-865;
Masubuchi, Y
- You have accessCytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.Y Masubuchi, S Hosokawa, T Horie, T Suzuki, S Ohmori, M Kitada and S NarimatsuDrug Metabolism and Disposition November 1994, 22 (6) 909-915;
N
Nakata, F
- You have accessSpecies differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl)phthalate, a peroxisome proliferator.M Hosokawa, K Hirata, F Nakata, T Suga and T SatohDrug Metabolism and Disposition November 1994, 22 (6) 889-894;
Narimatsu, S
- You have accessCytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.Y Masubuchi, S Hosokawa, T Horie, T Suzuki, S Ohmori, M Kitada and S NarimatsuDrug Metabolism and Disposition November 1994, 22 (6) 909-915;
Nau, H
- You have accessIdentification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos.G Tzimas, J O Sass, W Wittfoht, M M Elmazar, K Ehlers and H NauDrug Metabolism and Disposition November 1994, 22 (6) 928-936;
Nicoll-Griffith, D A
- You have accessIncreased cosedimentation of cytosolic glutathione S-transferases with microsomal fractions prepared from frozen rat liver.A E Cribb, G P Griffin, S P Spielberg, T H Rushmore, N Chauret and D A Nicoll-GriffithDrug Metabolism and Disposition November 1994, 22 (6) 969-972;
O
O'Dwyer, P J
- You have accessStereoselective pharmacokinetics of L-buthionine SR-sulfoximine in patients with cancer.F P Lacreta, J M Brennan, T C Hamilton, R F Ozols and P J O'DwyerDrug Metabolism and Disposition November 1994, 22 (6) 835-842;
Ohmori, S
- You have accessCytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.Y Masubuchi, S Hosokawa, T Horie, T Suzuki, S Ohmori, M Kitada and S NarimatsuDrug Metabolism and Disposition November 1994, 22 (6) 909-915;
Ozols, R F
- You have accessStereoselective pharmacokinetics of L-buthionine SR-sulfoximine in patients with cancer.F P Lacreta, J M Brennan, T C Hamilton, R F Ozols and P J O'DwyerDrug Metabolism and Disposition November 1994, 22 (6) 835-842;
P
Paroli, L
- You have accessIdentification of hepatocytes as the major locus of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1-related P450s, TCDDAA and TCDDAHH, in chick embryo liver.L Paroli, C Lee and A B RifkindDrug Metabolism and Disposition November 1994, 22 (6) 962-968;
Pitzenberger, S M
- You have accessHepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites.L E Los, S M Pitzenberger, H G Ramjit, A B Coddington and H D ColbyDrug Metabolism and Disposition November 1994, 22 (6) 903-908;
Pramanik, B N
- You have accessUrinary metabolites of (R),(R)-labetalol.K B Alton, T M Chan and B N PramanikDrug Metabolism and Disposition November 1994, 22 (6) 866-872;
R
Ramjit, H G
- You have accessHepatic metabolism of spironolactone. Production of 3-hydroxy-thiomethyl metabolites.L E Los, S M Pitzenberger, H G Ramjit, A B Coddington and H D ColbyDrug Metabolism and Disposition November 1994, 22 (6) 903-908;
Rettie, A E
- You have accessRelationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.S D Hall, M A Hamman, A E Rettie, L C Wienkers, W F Trager, M Vandenbranden and S A WrightonDrug Metabolism and Disposition November 1994, 22 (6) 975-978;
Rifkind, A B
- You have accessIdentification of hepatocytes as the major locus of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1-related P450s, TCDDAA and TCDDAHH, in chick embryo liver.L Paroli, C Lee and A B RifkindDrug Metabolism and Disposition November 1994, 22 (6) 962-968;
Rushmore, T H
- You have accessIncreased cosedimentation of cytosolic glutathione S-transferases with microsomal fractions prepared from frozen rat liver.A E Cribb, G P Griffin, S P Spielberg, T H Rushmore, N Chauret and D A Nicoll-GriffithDrug Metabolism and Disposition November 1994, 22 (6) 969-972;
S
Sarkar, M A
- You have accessTheophylline N-demethylations as probes for P4501A1 and P4501A2.M A Sarkar and B J JacksonDrug Metabolism and Disposition November 1994, 22 (6) 827-834;
Sass, J O
- You have accessIdentification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos.G Tzimas, J O Sass, W Wittfoht, M M Elmazar, K Ehlers and H NauDrug Metabolism and Disposition November 1994, 22 (6) 928-936;
Satoh, T
- You have accessSpecies differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl)phthalate, a peroxisome proliferator.M Hosokawa, K Hirata, F Nakata, T Suga and T SatohDrug Metabolism and Disposition November 1994, 22 (6) 889-894;
Schran, H F
- You have accessPharmacokinetics and metabolism of cyclosporin G in humans.J B Mangold, H F Schran and F L TseDrug Metabolism and Disposition November 1994, 22 (6) 873-879;
Semple, H A
- You have accessPropranolol disposition in the single-pass isolated, perfused rat liver in the presence and absence of insulin and glucagon.H A Semple and F XiaDrug Metabolism and Disposition November 1994, 22 (6) 822-826;
Shaw, L M
- You have accessMetabolic pathways of WR-2721 (ethyol, amifostine) in the BALB/c mouse.L M Shaw, H S Bonner and D Q BrownDrug Metabolism and Disposition November 1994, 22 (6) 895-902;
Spielberg, S P
- You have accessIncreased cosedimentation of cytosolic glutathione S-transferases with microsomal fractions prepared from frozen rat liver.A E Cribb, G P Griffin, S P Spielberg, T H Rushmore, N Chauret and D A Nicoll-GriffithDrug Metabolism and Disposition November 1994, 22 (6) 969-972;
Stein, H
- You have accessThe orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.J F Denissen, B A Grabowski, M K Johnson, S A Boyd, J T Uchic, H Stein, S Cepa and P HillDrug Metabolism and Disposition November 1994, 22 (6) 880-888;
Suga, T
- You have accessSpecies differences in the induction of hepatic microsomal carboxylesterases caused by dietary exposure to di(2-ethylhexyl)phthalate, a peroxisome proliferator.M Hosokawa, K Hirata, F Nakata, T Suga and T SatohDrug Metabolism and Disposition November 1994, 22 (6) 889-894;
Suzuki, T
- You have accessCytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.Y Masubuchi, S Hosokawa, T Horie, T Suzuki, S Ohmori, M Kitada and S NarimatsuDrug Metabolism and Disposition November 1994, 22 (6) 909-915;
T
Thomas, F
- You have accessPharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis.E Ezan, P Carde, J Le Kerneau, T Ardouin, F Thomas, F Isnard, E Deschamps de Paillette and J M GrognetDrug Metabolism and Disposition November 1994, 22 (6) 843-848;
Thummel, K E
- You have accessInterpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.K S Lown, J C Kolars, K E Thummel, J L Barnett, K L Kunze, S A Wrighton and P B WatkinsDrug Metabolism and Disposition November 1994, 22 (6) 947-955;
Trager, W F
- You have accessRelationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.S D Hall, M A Hamman, A E Rettie, L C Wienkers, W F Trager, M Vandenbranden and S A WrightonDrug Metabolism and Disposition November 1994, 22 (6) 975-978;
Tse, F L
- You have accessPharmacokinetics and metabolism of cyclosporin G in humans.J B Mangold, H F Schran and F L TseDrug Metabolism and Disposition November 1994, 22 (6) 873-879;
Tzimas, G
- You have accessIdentification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos.G Tzimas, J O Sass, W Wittfoht, M M Elmazar, K Ehlers and H NauDrug Metabolism and Disposition November 1994, 22 (6) 928-936;
U
Uchic, J T
- You have accessThe orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans.J F Denissen, B A Grabowski, M K Johnson, S A Boyd, J T Uchic, H Stein, S Cepa and P HillDrug Metabolism and Disposition November 1994, 22 (6) 880-888;
V
Vandenbranden, M
- You have accessRelationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.S D Hall, M A Hamman, A E Rettie, L C Wienkers, W F Trager, M Vandenbranden and S A WrightonDrug Metabolism and Disposition November 1994, 22 (6) 975-978;
W
Watkins, P B
- You have accessInterpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.K S Lown, J C Kolars, K E Thummel, J L Barnett, K L Kunze, S A Wrighton and P B WatkinsDrug Metabolism and Disposition November 1994, 22 (6) 947-955;
Wienkers, L C
- You have accessRelationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.S D Hall, M A Hamman, A E Rettie, L C Wienkers, W F Trager, M Vandenbranden and S A WrightonDrug Metabolism and Disposition November 1994, 22 (6) 975-978;
Wittfoht, W
- You have accessIdentification of 9,13-dicis-retinoic acid as a major plasma metabolite of 9-cis-retinoic acid and limited transfer of 9-cis-retinoic acid and 9,13-dicis-retinoic acid to the mouse and rat embryos.G Tzimas, J O Sass, W Wittfoht, M M Elmazar, K Ehlers and H NauDrug Metabolism and Disposition November 1994, 22 (6) 928-936;
Wrighton, S A
- You have accessInterpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.K S Lown, J C Kolars, K E Thummel, J L Barnett, K L Kunze, S A Wrighton and P B WatkinsDrug Metabolism and Disposition November 1994, 22 (6) 947-955;
- You have accessRelationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.S D Hall, M A Hamman, A E Rettie, L C Wienkers, W F Trager, M Vandenbranden and S A WrightonDrug Metabolism and Disposition November 1994, 22 (6) 975-978;
X
Xia, F
- You have accessPropranolol disposition in the single-pass isolated, perfused rat liver in the presence and absence of insulin and glucagon.H A Semple and F XiaDrug Metabolism and Disposition November 1994, 22 (6) 822-826;
Z
Zenser, T V
- You have accessGlucuronidation of N-acetylbenzidine by human liver.S R Babu, V M Lakshmi, T V Zenser and B B DavisDrug Metabolism and Disposition November 1994, 22 (6) 922-927;
In this issue

Advertisement